期刊文献+

干扰素α-2b对胰腺纤维化大鼠Ⅲ型胶原和纤维连接蛋白表达的影响 被引量:3

Effects of interferon α-2b on expression of collagen Ⅲ and fibronectin of pancreatic fibrosis in rats.
下载PDF
导出
摘要 目的观察干扰素α-2b对大鼠实验性胰腺纤维化Ⅲ型胶原和纤维连接蛋白合成的影响。方法采用每周2次腹腔内注射二乙基二硫代氨基甲酸盐(diethyldithio carbamate,DDC)1000mg/kg体重诱导健康雄性Wistar大鼠胰腺纤维化。干扰素α-2b治疗组(n=10)在造模日起每天1次皮下注射干扰素α-2b100000U,连续6周。对照组(n=10)注射等容积生理盐水。6周末处死大鼠,取新鲜胰腺组织,10%甲醛溶液固定,常规石蜡包埋切片,观察病理改变。免疫组织化学染色检测Ⅲ型胶原和纤维连接蛋白。结果干扰素α-2b治疗组腺泡细胞炎症反应和纤维化程度较对照组减轻;干扰素α-2b治疗组Ⅲ型胶原和纤维连接蛋白量分别为88.14±42.58和2.37±1.56,较对照组的59.95±25.50和1.50±0.31显著减少(P〈0.05)。结论干扰素α-2b可能通过减少胰腺组织内Ⅲ型胶原和纤维连接蛋白的合成起到治疗胰腺纤维化的作用。 Objective To investigate the effect of interferon α-2b on the expression of collagen Ⅲ and fibronectin in the pancreatic tissue of rats with pancreatic fibrosis. Methods The pancreatic fibrosis model was induced by intra abdominal injection with diethyldithio carbamate solution 1 000 mg/kg weight twice per week. Twenty Wistar rats were randomly divided into 2 groups (n=10) : control group and interferon α-2b treatment group. The rats in α-2b interferon treatment group were hypodermic injected with α-2b interferon 100 000 unit/kg weight once per day for 6 weeks, while the control group was treated with the same volume saline. At the end of the 6th week, these rats were sacrificed and the pancreatic tissues were taken to do the following experiments: 1. HE staining was used to evaluate the degree of inflammation. 2. The expression of collagen Ⅲ and fibronectin were detected by immunohistochemistry. Results Both the degree of inflammation and fibrosis in the control group were more serious than the α-2b interferon treatment group. Moreover the expression of collagen Ⅲ (88.14 ± 42.58) and fibronectin (2. 37 ± 1. 56) in interferona-2b treatment group was markedly reduced as compared with those in the control group (59.95 ± 25.50 and 1. 50 ± 0.31, P 〈 0.05). Conclusions Interferon α-2b may decrease the expression of collagen Ⅲ and fibronectin, which may play a role in antifibrosis therapy of pancreas.
出处 《胰腺病学》 2007年第5期326-328,共3页 Chinese JOurnal of Pancreatology
关键词 胰腺炎 纤维化 干扰素Α-2B 胶原Ⅲ型 纤维连接蛋白 Pancreatitis Fibrosis Interferon Alfa-2b Collagen type Ⅲ Fibronectin
  • 相关文献

参考文献14

  • 1马晶晶,王兴鹏.胰腺星状细胞与胰腺纤维化[J].国外医学(消化系疾病分册),2005,25(4):215-217. 被引量:7
  • 2Bachem MG,Schneider E,Gross H,et al.Identification,culture,and characterization of pancreatic stellate cells in ratsand humans.Gastroenterology,1998,115:421-432.
  • 3Madro A,Celinski K,Slomka M,et al.The role of pancreatic stellate cells and cytokines in the development of chronic pancreatitis.Med Sci Monit,2004,10:RA166-170.
  • 4Haber PS,Keogh GW,Apte MV,et al.Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis.Am J Pathol,1999,155:1087-1095.
  • 5Apte MV,Haber PS,Darby SJ,et al.Pancreatic stellate cells are activated by proinflammatory cytokines:implications for pancreatic fibrogenesis.Gut,1999,44:534-541.
  • 6孙蕴伟,袁耀宗.纤维化疾病的基础和临床.上海:上海科学技术出版社,2004:154-155.
  • 7高晓方,崔社怀.干扰素γ及地塞米松对实验性肺纤维化大鼠血清IL-4、SP-A含量的影响[J].实用医学杂志,2004,20(5):498-500. 被引量:5
  • 8Numaguchi S,Okuno M,Moriwaki H,et al.Modulation of collagen synthesis and degeradation by retinoids and cytokines in 3T3L1 preadipocytes.Intern Med,1994,33:309-316.
  • 9Teran JC,Mullen KD,Hoofnagle JH,et al.Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon-alpha.Hepatology,1994,19:849-856.
  • 10Ishibashi K,Kashiwagi T,Ito A,et al.Changes in serum fibrogensis markers during interferon therapy for chronic hepatitis type C.Hepatology,1996,24:27-31.

二级参考文献22

  • 1Wallace WA, Ramage EA, Lamb D, et al. A type-2 (Th2-1ike) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol, 1995,101(3): 436-441
  • 2Gurujeyalakshmi G, Giri SN. Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregtulation of TGF - beta and procollagen Ⅰ and Ⅲ gene expression. Exp Lung Res, 1995, 21(5) :791 - 808
  • 3Lasky JA, Ortiz LA. Antifibrotic therapy for the treatment of pulmonary fibrosis. Am J Med Sci, 2001, 322(4) :213 - 221
  • 4Ando M, Miyazaki E, Fukami T, et al. Interleukin-4-producing cells in idiopathic pulmonary fibrosis: an immunohistochemical study. Respirology, 1999, 4(4):383-391
  • 5Hagimoto N, Kuwano K, Miyazaki H, et al. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am J Respir Cell Mol Bio, 1997, 17(3): 272-278
  • 6Apte MV, Haber PS, Darby SJ, et al. Gut, 1999;44:534~541.
  • 7Vogelmann R, Ruf D, Wagner M, et al. Am J Physiol Gastrointest Liver Physiol, 2001 ; 280 : G164~ 172.
  • 8Jaster R, Sparmann G, Emmrich J, et al. Gut, 2002;51 :579~584.
  • 9Phillips PA,Wu MJ, Kumar RK, et al. Gut, 2003;52:677~682.
  • 10Masamune A, Kikuta K, Satoh M, et al. Tohoku J Exp Med,2003 ; 199 : 69~84.

共引文献15

同被引文献30

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部